They sell this device from an expensive address in London. If they end up no longer selling the device due to it failing the trials then I would imagine their profits would plummet. Game over or thereabouts I would have said. I'm trying to illustrate the point that they must have a great deal of faith in this product.
Whatever anyway, if people want to be negative then carry on.
Yes, and my point is that the Tinnitus Clinic wasn't dependent on this device before. If the trials failed -> product would no longer sell -> profits could decrease from the current ones, but by how much? Is there any data available how many of these devices they have currently sold? It's so expensive in the UK that I figure not that many tinnitus sufferers have opted for it currently.
The question, therefore, is: what's the amount of their revenue this device is responsible for. I would think it's minimal, but that's not based on any inside knowledge whatsoever.
I'm sorry if I come off as negative. Honest to god I wish this device works. Why would
anyone wish this device failed is beyond me. I'm always just trying to be a bit of a realistic when it comes to tinnitus treatments so I don't end up sorely disappointed.
By the way, this isn't meant to sound like coming from a conspiracy theorist, but:
This study I earlier quoted: http://www.ncbi.nlm.nih.gov/pubmed/22414611
Was organized by Research Center Jülich, Institute for Neuroscience and Medicine-Neuromodulation INM-7, Jülich, Germany. p.tass@
fz-juelich.de
->
http://www.fz-juelich.de/portal/EN/Research/Health/Neurostimulator/_node.html
"In order to translate the research results into medical products for use in patients,
the Jülich-based company Adaptive Neuromodulation (ANM), a spin-off of Forschungszentrum Jülich, was founded in 2005."
I had no clue earlier that this study was carried out by a research center company off of which the ANM was founded as a spin-off.
Some people might not call the study I quoted completely unbiased based on these findings.
This just brings Neuromonics to mind a bit, where the company itself announced pretty good results, but then later on 3rd party trials found no difference between Neuromonics and regular white noise therapy. Which is what I absolutely hope doesn't happen with ACR.
I'm going to stay away from this thread until further results are available about the treatment. There's nothing I can do to accelerate the process, so it's best to keep to myself and hope for the best.
Still, if SISKO happens to read this, I hope he can share his opinion about this treatment as Germans have had it for longer now.